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ABSTRACT
Objective The Arthritis Self-Efficacy Scale (ASES) was
designed to assess the degree of self-efficacy among
patients with arthritis. Though the original English version
of this instrument has shown a high degree of reliability
and validity, a Chinese version of this scale has yet to
be validated. Therefore, the aim of this cross-sectional
study was to evaluate the psychometric characteristics of
the Chinese version of ASES (C-ASES) in a population of
Chinese adults with rheumatic diseases (RDs).
Methods After completing backward translation and
expert validity, a convenient sample of 258 qualified
participants with RDs from a hospital in Taiwan were
recruited to explore the content validity, concurrent validity,
construct validity, internal consistency reliability and test–
retest reliability of C-ASES.
Results The C-ASES has demonstrated acceptable
internal consistency and test–retest reliability, with a
Cronbach α of 0.91 and intraclass correlation coefﬁcient
of 0.89, respectively. Concurrent validity was acceptable,
with significant correlation between the subscales of the
C-ASES and perceived depressive symptoms, as measured
by the Taiwanese Depression Questionnaire (p<0.05). The
exploratory factor analysis revealed a three-factor solution
(physical function, experienced pain and other symptoms)
corresponding to the structure of the original instrument,
which accounted for 59.78% of the total variance.
Conclusion Empirical data support the assertion that C-
ASES is a reliable and valid screening instrument to assess
self-efficacy in Chinese-speaking patients with RDs.
C-ASES may be useful as a reference guide in providing
appropriate interventions for bolstering self-efficacy
among Chinese-speaking patients with RDs.

INTRODUCTION
Rheumatic diseases (RDs) are common
conditions that affect the joints or the tissues
surrounding the joint and other connective tissue. According to the US Centers for
Disease Control and Prevention, more than
50 million adults in the USA have physician-
diagnosed arthritis, accounting for nearly
one-fifth of adults experiencing this disorder.1
The common symptoms of RDs include

Strengths and limitations of this study
►► Disease-
specific measures offer valuable insights

into the impact of a disease on various aspects of
a patient’s life.
►► The topic of self-efficacy (SE) in patients with chronic diseases especially rheumatic diseases (RDs) has
attracted much attention because higher levels of SE
have been found to be associated with better coping
with the disease and its clinical manifestations.
►► As of now, no study has yet examined English to
Chinese translation of the Arthritis Self-
Efficacy
Scale (ASES) or its psychometric properties among
Chinese adults with RDs.
►► The results of our study show that the ASES has
good psychometric properties when it is applied to
patients with RDs.
►► The geographical and sociocultural limitations of the
sample may restrict generalisability of the findings.

swelling, stiffness and decreased range of
motion, all of which may lead to permanent
disability. The estimated direct medical cost
in 2003 for US patients with arthritis or other
rheumatic conditions was $80.8 billion, with
the total societal costs (the sum of direct costs
and indirect costs) estimated at $128 billion.2
Similarly, in Taiwan, the annual healthcare
expenditure for RDs treatment has increased
over time, from 5.8 billion New Taiwan Dollars
(NTD) in 2016, 6.3 billion NTD in 2017 to
7.1 billion NTD in 2018.3 In addition to the
enormous economic costs of RDs, they may
trigger other illnesses. Some studies indicate
that RDs may be associated with increased
risks of kidney dysfunction, psychiatric disorders and cardiovascular diseases.4–6 Accordingly, patients with RDs have a 20% greater
risk of all-cause mortality compared with the
general population.7 Given these daunting
figures, optimum disease control is essential
to prevent or delay the complications associated with RDs.
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As patients are responsible for monitoring their disease
daily, it is crucial that they maintain sufficient knowledge,
skills and positive attitudes towards arthritis. The concept
of self-
efficacy (SE) has attracted increasing attention
in clinical practice.8–11 The term was coined by Albert
Bandura, an early cognitive psychologist. Bandura defined
SE as a belief in one’s ability to succeed in specific situations, accomplish a task or achieve a certain goal.12 The
robust relationship between SE and self-care behaviours
has been established among patients with RDs.8 Using
SE models in designing educational interventions can
significantly enhance self-management routines, which in
turn lessen the risk of poor clinical outcomes, and assist
patients in coping successfully with the manifestations of
arthritis.9 13 These findings further indicated the need to
evaluate SE before implementing therapeutic interventions for patients with RDs.
Following a detailed literature review, we discovered
that SE and its related measures have been widely used,
particularly via the Arthritis Self-Efficacy Scale (ASES).9 14
This scale was created by Lorig and colleagues in the late
1980s.15 The full 20-item ASES consists of three subscales
(namely, pain, physical function and other symptoms)
and has been validated and widely applied in many
countries to measure degree of SE, including Sweden,16
Norway,17 Iran18 and Turkey.11 Although these studies
provide important references for the local context, to the
best of our knowledge, the ASES has not been verified
for its psychometric characteristics in individuals with
arthritis in Chinese. Given these issues, this study aimed to
explore the validity and reliability of the Chinese version
of ASES (C-ASES) in Chinese arthritis subjects.

METHODS
Study design and participants
This cross-
sectional study adopted a convenience
sampling approach to recruit people with RDs from
outpatient departments at a teaching hospital in Taiwan
during 2018. The main inclusion criteria were as follows:
(a) having physician-diagnosed RDs, such as ankylosing
spondylitis, rheumatoid arthritis, Sjogren’s syndrome,
gout or systemic lupus erythematosus, (b) being older
than 20 years and willing to participate in the study
and (c) being able to communicate in either Mandarin
Chinese or Taiwanese. Individuals who were unable to
care for themselves or had physician-diagnosed psychiatric disorders before entry were excluded.
Sample size calculation
The sample size needed for this study was determined by
Gorsuch’s suggestion, which indicated that a minimum
subject-to-item ratio for conducting factor analysis should
be at least 5:1.19 Accordingly, because 20 items comprised
the ASES, a sample of at least 100 subjects was required
for sound data analysis. During the study period, 258
participants were recruited for data analysis.
2

Ethics
All of the potential participants were informed of the
research purposes, procedures and their rights, and were
required to provide written consent before participation.
Additionally, all participants were informed of their rights
under the Declaration of Helsinki.
Instruments
Three measures were used to survey the enrolled patients:
ASES, the Taiwanese Depression Questionnaire (TDQ)
and a questionnaire requesting demographic variables
and clinical characteristics.
SE, the main focus of this study, was assessed by ASES.
This measure was developed by Lorig and colleagues to
identify and quantify SE among individuals with RDs.15
It is composed of 20 items clustered into three subscales
of physical function (9 items), other symptoms (6 items)
and pain (5 items), all scored on a 10-point (10–100)
scale, with higher scores indicating greater SE. The
instrument had been shown to have adequate reliability
and to be a sensitive measure of SE for individuals with
RDs.9 10 16 17 20 After obtaining consent from the scale
developer (Dr Lorig), we used the reverse-
translation
method to improve the cultural validity and ensure the
usefulness of ASES.21
Initially, this scale was translated into Chinese by two
independent translators of Taiwanese descent who were
fluent in both the original and the target languages to
complete the forward translation. Any inconsistent or
ambiguous phrase was highlighted and later agreed on
following a thorough discussion between the two translators. Following this step, an additional independent
English native-speaking translator who had not seen the
questionnaire previously was invited to carry out the backward translation. Subsequently, a panel comprised of the
principal researcher and all translators held a discussion
which aimed to determine whether the adopted words
and items conveyed the same meaning and confirmed
that the used equivalent expressions did not, indeed,
alter the cultural meaning of the original wordings.
Throughout the translation procedure, we kept close
contact with Dr Lorig, via email, to ascertain semantic
consistency between the original copy and the back-
translated English version. Following these translational
steps, we finished the development of C-ASES (see online
supplemental file).
The TDQ is a 20-item self-reported questionnaire developed by Lee and colleagues to assess level of depression.22
Each item is scored on a 0–3 level, with the total scores
ranging between 0 and 54. Higher scores indicate greater
psychological distress. Presently, it has been shown to be a
psychometrically sound measure when used for Taiwanese
patients with chronic illness.23 24 For example, after
applying the Structured Clinical Interview of the DSM-
III-R diagnostic criteria as the gold standard, the TDQ
showed good concurrent validity.22 The area under the
received operating characteristics curve of the TDQ was
0.92. In regard to its reliability, the TDQ had previously
Tsai T-Y, et al. BMJ Open 2021;11:e042014. doi:10.1136/bmjopen-2020-042014
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demonstrated good internal consistency among different
groups of subjects, with Cronbach’s α ranging from 0.89
to 0.92.22–24Cronbach’s α for the present data was 0.92.
In the current study, it was applied to examine the same-
time validity value between TDQ and C-ASES, since less
depressed individuals have been shown to have higher
SE and maintain higher positive health behaviours.25 For
this reason, a reversed relationship is assumed to exist
between SE and depression.
Lastly, through the medical chart review, we obtained
data on each respondent’s demographic and clinical characteristics, including sex, age, marital status, education
level and household status. The clinical characteristics
studied included the duration of RDs and comorbidity
(defined as having at least one of the following diseases
for at least 6 months duration: diabetes, hypertension,
heart disease, stroke and cancer).
Data collection procedure
Before enrolling in the study, all participants received
detailed written and verbal information on the aims and
protocol of the study and signed an informed consent
form. Throughout the procedure of data collection, all
questionnaires were returned with no identifying personal
information and were marked only with an encryption
code to facilitate data analysis. The encryption rules were
available to the researchers only. To investigate the test–
retest reliability of C-ASES, we administered the C-ASES
again after 2 weeks to a convenience sample of 100 from
the original participants.
Data analysis
The obtained data were analysed using SPSS V.16.0 for
Windows (SPSS, Chicago, Illinois, USA). The characteristics of subjects and the mean±SD values of the main
study variables were analysed. The reliability of C-ASES
was estimated by calculating the internal consistency and
test–retest reliability. Internal consistency of the scale was
established using standard statistical procedures described
by Cronbach’s α, and a Cronbach’s α higher than 0.70 was
considered satisfactory.26 The test–retest reliability was
assessed using the intraclass correlation coefficient (ICC)
together with the Bland-Altman procedure. The latter
approach is a graphical technique that assesses the agreement between two measurements. By plotting the differences against the mean between two measuring points,
it can disclose the magnitude of disagreement, highlight
the outliers and facilitate identification of trend. Two
rules suggested by Altman and Bland were used to the
assessment of comparability.27 One is to discern whether
the mean of differences was significantly different from 0.
The other is to test the dependency between difference
and average of the two measurements by fitting a linear
regression line, and a significant change in the slope of
the regression line indicates disagreement between the
two measurements.
In terms of validity measures, we examined the scale’s
content validity, face validity, concurrent validity and
Tsai T-Y, et al. BMJ Open 2021;11:e042014. doi:10.1136/bmjopen-2020-042014

construct validity. Regarding the content validity, several
experts in related fields were invited to examine the
overall appearance of the pre-final version of the scale. To
further support the scale’s content validity index (CVI),
we asked the expert panel to evaluate each item of the
instrument using a 4-point scale (1=not relevant, 2=somewhat relevant, 3=quite relevant and 4=highly relevant). A
pilot study was then performed to test the face validity of
the items, which involved 30 participants from the target
population. As to the construct validity of C-ASES, it was
assessed using factor analysis. The Kaiser-
Meyer-
Olkin
(KMO) measure of sampling adequacy and Bartlett’s test
of sphericity were used to determine whether the data
were appropriate for factor analysis. Theoretically, a value
of KMO below 0.50 means samples are not sufficient for
factor analysis, whereas values above 0.90 are more than
sufficient for factor analysis.19 28 In order to determine
the factorial structure of the scale, the principal components analysis was used to extract the factors, and varimax
rotation was used to obtain the most meaningful original
factor structure of the C-ASES. Regarding the concurrent
validity, it was determined through the assessment of relation between C-ASES and TDQ by the Pearson correlation coefficient.
Patient and public involvement
Our participants took part in a pre-survey and a formal
survey following the completion of the scale. Participation
was voluntary, and no incentives were provided for participation. Participants were not directly involved in the
design or development of research questions. The results
of the study were not provided to individual participants.

RESULTS
Sample characteristics
Table 1 shows the distribution of demographic data and
clinical characteristics among the enrollees. During the
recruitment period, 258 patients with RDs were enrolled.
The mean age of participants was 57.1 years (±14.1 years),
and the majority were women (74.4%), married (84.5%)
and had a high level of education (51.2%), as well as a
monthly income of ≤30 000 NTD (66.3%). In terms of
disease characteristics, most respondents had no other
comorbidities (54.3%), and their mean duration of RDs
was 8.4 years (±5.1 years).
Reliability
The internal reliability of the C-ASES, as assessed by Cronbach’s α, was 0.82, 0.84 and 0.89 for the pain, other symptoms and physical function subscales, respectively, and
0.91 for the total scale (table 2). The item-total correlations ranged from 0.48 to 0.73. In the test–retest investigation, 4 of the 100 individuals had missing data at the
second measurement; thus, calculation of test–retest reliability was performed on data provided by 96 subjects via
ICC and the Bland-Altman analysis. The ICC was 0.89 for
the C-ASES total scores, 0.85 for the pain subscale, 0.88
3
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Table 1 Demographic and clinical characteristics of enrolled subjects
Subjects of convince sample
(n=96)

All subjects (n=258)
Variable

Mean±SD

N (%)

Mean±SD

N (%)

Demographic characteristics
Educational level
 High (≥ninth grade)

132 (51.2)

54 (56.2)

 Low (<ninth grade)

126 (48.8)

46 (43.8)

218 (84.5)

81 (84.4)

40 (15.5)

15 (15.6)

 ≤30 000 NTD

171 (66.3)

52 (54.2)

 >30 000 NTD

87 (33.7)

44 (45.8)

192 (74.4)

79 (82.3)

66 (25.6)

17 (82.3)

Martial status
 Married
 Single
Monthly income

Sex
 Female
 Male
Age (years)

57.1 (14.1)

53.8 (10.9)

Clinical characteristics
Comorbidity
118 (45.7)

 Yes

140 (54.3)

 No
Disease duration (years)

8.4 (5.1)

68 (70.9)
28 (29.1)
5.1 (4.3)

NTD, New Taiwan Dollars.

for the other symptoms’ subscale and 0.90 for the physical
function subscale; all supported the test–retest reliability.
In addition, the plot from the Bland-Altman test showed
that most of the measured differences between the first
and the second measurements approached 0 and fell
within the limits of agreement (mean±1.96 SD; figure 1),
and the change in the slope of linear regression line did
not reach statistical significance (β=0.341; p=0.11).

Concurrent validity
Table 3 shows the concurrent validity of the C-ASES as
assessed by correlation analysis with the TDQ. Significantly moderate correlations were found between TDQ
and the pain, physical function and other symptoms
subscales, with correlation coefficients of −0.53 to –0.54
and −0.67, respectively. The negative correlation coefficients indicate that a higher level of depression was
related to a lower degree of SE.

Content validity and face validity
A panel of clinical rheumatological experts conducted
a CVI test. The instrument was sent to four experts,
covering two rheumatologists, one nurse with over 5 years
of nursing experience in the rheumatologic department
and a nursing professor to assess whether each item
was relevant and appropriate as an indicator of the SE
construct. The panel of experts used a 4-point Likert scale
to evaluate the content of the C-ASES for relevance of
content, comprehensiveness of measure and clarity of
items, while considering the cultural context appropriateness for each item. The CVI for the C-ASES in this survey
was 0.91. In addition, the pre-final C-ASES was examined
by interviewing 30 volunteers with RDs and requesting
that they make suggestions on any difficult-
to-
answer
items. Finally, no any problematic word was reported after
the process.

Construct validity
We further applied exploratory factor analysis to
confirm the construct validity of the C-A SES. First,
the KMO method and Bartlett’s test of sphericity were
used to assess the suitability of factor analysis. The
KMO value was 0.90, and the statistical significance of
Bartlett’s test of sphericity (χ 2=3160.34; p<0.001) indicated a highly compact pattern of inter-item correlations, thus justifying the use of factor analysis. 15 19 29 A
principal component analysis with varimax rotations
extracted three factors from these 20 items, based
on eigenvalues greater than 1.0 and factor loading
greater than 0.4; each item loaded onto the 3 established domains as expected and explained 59.78%
of the total variance. Factor 1 appears to reflect a
‘physical function’ factor based on the content of its
9 items, explaining 30.97% of the total item variance.
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Table 2 Mean values, SD, correlations and Cronbach’s
alpha coefficients of items of the C-ASES
Items

Mean

SD

r

 Q1

72.25

34.10

0.60

 Q2

84.69

24.53

0.68

 Q3

79.53

30.87

0.66

 Q4

49.03

37.76

0.49

 Q5

47.25

37.82

0.48

 Q1

91.36

21.77

0.54

 Q2

72.91

33.17

0.59

 Q3

85.62

27.85

0.65

 Q4

94.22

18.07

0.60

 Q5

94.11

18.17

0.58

 Q6

95.39

15.13

0.54

 Q7

84.46

28.28

0.55

 Q8

92.75

21.82

0.60

 Q9

94.07

16.99

0.50

 Q1

80.50

32.08

0.51

 Q2

80.00

31.36

0.63

 Q3

81.82

31.00

0.60

 Q4

67.13

29.51

0.54

 Q5

80.74

27.00

0.73

 Q6

81.32

28.25

0.55

Pain

Physical function

All

Bivariate correlations of the C-ASES and the TDQ

Cronbach’s α

ASES

TDQ

0.82

Physical function
Other symptoms

−0.54*
−0.67*

Pain
Total

−0.53*
−0.69*

0.89

Other symptoms

Table 3
(n=258)

**P<0.001.
ASES, Arthritis Self-Efficacy Scale; C-ASES, Chinese version of
ASES; TDQ, Taiwanese Depression Questionnaire.

Factor 2, which accounted for 16.91% of the variance, can be labelled ‘other symptoms’ based on the
content of its 6 items. The remaining 5 items explain
11.90% of the variance and correspond to the third
factor ‘pain’ (table 4).

0.84

0.91

DISCUSSION
Main findings
Aside from receiving proper medical treatment, a
patient’s perceived SE is also crucial in improving clinical prognosis. 15 The timely awareness of SE has been
recognised as a first step in instituting appropriate
interventions. 8 14 To the best of our knowledge, this
is the first study to assess the reliability and validity
of ASES in Chinese patients with RDs, allowing for
future validation of its psychometric properties in
people of other cultures.

Figure 1 Bland-Altman plot assessing agreement between
two measuring points.

Comparison of the current study with previous studies
Reliability assessment
Findings from our study indicated that the Cronbach’s α of C-A SES total score, the pain, physical function and other symptoms subscales were 0.91, 0.82,
0.89 and 0.84, respectively, all of which conformed
to the typically established criterion that α should
be greater than 0.7. 24 30 After an extensive review of
the literature, we found only the internal consistency
measured by Cronbach’s α was reported, ranging
from 0.76 to 0.91, 8 9 14 16 and our estimations did not
differ much from those. In addition, in our study,
the item-t o-t otal score correlations ranged from 0.48
to 0.73, indicating that individual items were consistent with the scale’s assessed construct. A major
contribution of the present study is to examine the
reproducibility as determined by ICC as well as the
Bland-A ltmann analysis. ICC values for the total scale
and the subscales were all greater than 0.80. Moreover, the plot from Bland-A ltmann analysis revealed
that the discrepancies between two measuring points
were random and almost all fell within the 95% limits
of agreement. It can, therefore, be concluded that
the C-
A SES has satisfactory reproducibility among
Chinese patients with RDs. Of particular importance
was that the majority of previous studies merely

Tsai T-Y, et al. BMJ Open 2021;11:e042014. doi:10.1136/bmjopen-2020-042014
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Table 4 Exploratory factor analysis of C-ASES
Items

Eigenvalue

Variance
explained (%)

Factor 1: physical function
Q13. Are you confident that you are able to enter or get out of the
passenger seat of a car without assistance from other people or
assistive devices?

8.19

30.97

Factor
loading
0.80

Q9. Are you confident that you can fasten and unfasten three medium-
sized buttons in a row within 12 s?

0.79

Q10. Are you confident that you can use a knife and fork to cut two
roughly bite-sized pieces of meat within 8 s?

0.77

Q14. Are you confident that you can put on a long-sleeve or short-
sleeve shirt that opens at the front within 8 s (without fastening the
buttons)?

0.76

Q6. Are you confident that you can walk 100 feet on level ground within
20 s?

0.72

Q11. Are you confident that you can easily open or close an outdoor
faucet?

0.67

Q8. Are you confident that you can get out of an armless chair quickly
without using your hands at all?

0.66

Q12. Are you confident that you can use both hands to scratch your
upper back?

0.63

Q7. Are you confident that you can climb up 10 stairs in 7 s?

0.54

Factor 2: other symptoms

3.09

16.91

Q17. How confident are you that you can do something to help you
break out of a depressed mood?

0.76

Q19. How confident are you that you can adapt to your joint symptoms
and complete the tasks you wish to finish?

0.75

Q20. How confident are you that you can deal with the sense of
frustration that comes from your joint disease?

0.74

Q16. Are you confident that, after an adjustment in your level of activity,
your joint disease will not worsen?

0.67

Q15. Are you confident that you can control your fatigue?

0.61

Q18. Compared with other people with joint disease, how confident are
you that you can deal with your joint pain as you go about your daily
activities?

0.57

Factor 3: pain

2.20

11.89

Q5. How certain are you that you can make a large reduction in your
arthritis pain by using methods other than taking extra medication?

0.89

Q4. How certain are you that you can make a small-to-moderate
reduction in your arthritis pain by using methods other than taking
extra medication?

0.88

Q3. How confident are you that you can tolerate your joint pain enough
so that it will not affect your sleep?

0.61

Q1. How confident are you that you can significantly reduce your own
pain?

0.57

Q2. How confident are you that you can engage in most of your daily
activities?
Total

0.51
59.78

C-ASES, Chinese version of Arthritis Self-Efficacy Scale.

relied on Pearson product moment correlations to
determine test–retest reliability, 9 14 16 thus potentially
risking violation of the independence assumption
6

across variables and attenuating the psychometric
soundness of the ASES when applied across different
cultures.
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Validity assessment
The overall validity of C-ASES was supported by assessments
of its content, construct and concurrent validities. First, four
expert raters evaluated the clinical appropriateness of the
scale’s 20 items. None of the 20 items had a CVI lower than
0.80 and the overall CVI score was above 0.90, thus demonstrating good agreement among the four experts as to the
viability of the instrument to measure SE. Earlier studies
seldom reported CVI values of the ASES among patients
with arthritis,9 14 17 making a direct comparison to our findings impossible. However, our findings did meet the psychometric standard proposed by Polit and Beck in which the
item-level CVI should exceed 0.78.31
Another commonly used method to assess a questionnaire’s validity is through factor analysis.19 Before
performing the exploratory factor analysis, the KMO was
calculated to be 0.90, which indicated that the sample was
large enough for a satisfactory factor analysis.19 19 Therefore, we inferred that the size of the recruited sample
was abundant. Echoing earlier reports,15 16 the exploratory factor analysis extracted three factors which corresponded to the original ASES subscales. None of the
items demonstrated observable psychometric weaknesses,
and nearly 60% of the total scale variance was explained
by the three-
factor solution. Additionally, examination
of the concurrent validity revealed that higher levels of
depression were associated with lower SE, concurring
with former findings.25 Taken together, these findings are
consistent with earlier studies reporting that SE is linked
to, and predictive of, meaningful physical and psychological health outcomes among arthritic patients.8 9 13
Study strengths and weaknesses
This study provides evidence for semantic, construct and
conceptual equivalence of the C-ASES, but some limitations
are worth noting as additional directions for future research.
First, all participants were drawn from a single hospital in
southern Taiwan and, therefore, may not be representative of other Chinese-speaking populations. Future studies
should recruit larger samples or adopt random sampling
procedures to assess the applicability of the C-ASES to all
ethnically Chinese populations. Nonetheless, we considered
the sample size needed to ensure adequate statistical power
before initiating this preliminary study, so the sample size
appears to be satisfactory for the purposes of the current
study. Second, due to time constraints, the researchers were
unable to obtain data pertaining to the depression measure
over time, thus limiting the ability to examine the predictive
validity of C-ASES. Future research should use longitudinal
measurement of additional clinical prognostics, in addition
to depression, to investigate the utility of SE as a predictor
of the indicators of RA-triggered distress. Third, our findings focused mainly on the empirically driven subscales of
C-ASES, as derived by exploratory factor analysis rather than
confirmatory factor analysis. Nevertheless, the exploratory
factor analysis is more useful to investigate the original factor
structure of the instrument.27 Despite these methodological concerns, to the best of our knowledge, this was the first
Tsai T-Y, et al. BMJ Open 2021;11:e042014. doi:10.1136/bmjopen-2020-042014

study to determine the validity and reliability of ASES among
Chinese patients with RDs. The examination of the psychometric properties of the scale supported the usefulness of
ASES as a culturally appropriate instrument for the measurement of SE.
In conclusion, the results of this study, obtained by rigorous
procedures, confirm that the Chinese-language version of the
ASES possesses acceptable content, concurrent and construct
validities, as well as internal consistency and temporal
stability. This instrument may be useful for assessment of SE
and helpful for healthcare providers in tailoring appropriate
interventions for patients with RDs. Given that lower levels of
SE have been found, in prior studies, to be related to poorer
clinical outcomes, targeted screening and detection of influencing factors of SE may, therefore, represent an important
strategy for detecting and improving clinical manifestations
among patients with RDs.
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